Sandoz Urges Fed Circ. To Revive Combigan Generic Bid
Sandoz Inc. told the Federal Circuit on Thursday that a district court had wrongly refused to revisit a ruling that blocked its planned generic version of Allergan Inc.'s glaucoma drug Combigan,...To view the full article, register now.
Already a subscriber? Click here to view full article